Table 1 TCID50 titer determination of randomly selected RSV-NICA vials
From: Proof of stability of an RSV Controlled Human Infection Model challenge agent
Box ID | Sample ID | TCID50/ml (log10) | Average TCID50/ml ± SEM | Box ID | Sample ID | TCID50/ml (log10) | Average TCID50/ml ± SEM |
|---|---|---|---|---|---|---|---|
I | I1 | 4,80 | 4.93 ± 0.26 | VII | VII1 | 2,35 | 3.22 ± 0.76 |
I2 | 5,67 | VII2 | 2,52 | ||||
I3 | 4,45 | VII3 | 2,52 | ||||
I4 | 4,80 | VII4 | 5,49 | ||||
II | II1 | 4,80 | 5.23 ± 0.15 | VIII | VIII1 | 2,35 | 2.35 ± 0.00 |
II2 | 5,32 | VIII2 | 2,35 | ||||
II3 | 5,32 | VIII3 | 2,35 | ||||
II4 | 5,49 | VIII4 | 2,35 | ||||
III | III1 | 3,57 | 4.45 ± 0.34 | IX | IX1 | 2,52 | 3.05 ± 0.64 |
III2 | 4,27 | IX2 | 2,35 | ||||
III3 | 5,15 | IX3 | 4,97 | ||||
III4 | 4,80 | IX4 | 2,35 | ||||
IV | IV1 | 5,49 | 5.41 ± 0.21 | X | X1 | 5,49 | 5.67 ± 0.07 |
IV2 | 4,80 | X2 | 5,67 | ||||
IV3 | 5,67 | X3 | 5,67 | ||||
IV4 | 5,67 | X4 | 5,84 | ||||
V | V1 | 2,52 | 2.44 ± 0.05 | XI | XI1 | 3,40 | 2.83 ± 0.24 |
V2 | 2,35 | XI2 | 2,35 | ||||
V3 | 2,52 | XI3 | 2,52 | ||||
V4 | 2,35 | XI4 | 3,05 | ||||
VI | VI1 | 2,35 | 2.35 ± 0.00 | XII | XII1 | 5,15 | 4.23 ± 0.64 |
VI2 | 2,35 | XII2 | 4,80 | ||||
VI3 | 2,35 | XII3 | 2,35 | ||||
VI4 | 2,35 | XII4 | 4,62 |